The primary endpoint would be the 6-month angiographic and VH-IVUS restudy findings.

The secondary endpoint would be the occurrence of any major adverse cardiac events at 6 months (including any death, myocardial infarction or need for revascularization) as routinely monitored after all percutaneous interventional procedures.